Decision-Making Capacity and Legal Competence in Mental Health: Clinical and Legal Distinctions

Decision-making capacity and legal competence are related but fundamentally distinct concepts that govern a person's right to make autonomous decisions about their own care. Conflating the two is a common and consequential error in clinical practice.

Capacity is a clinical determination made by a treating physician or qualified clinician at the bedside. It refers to a patient's functional ability to make a specific decision at a specific point in time. Any licensed physician can assess capacity — it does not require a psychiatrist, though psychiatric consultation is frequently requested for complex cases. Capacity is evaluated through a structured clinical interview and documented in the medical record.

Competence is a legal determination made by a judge or court. A person is presumed competent unless a court formally rules otherwise. Legal competence is a broader, more enduring status that affects a person's rights to enter contracts, manage finances, vote, consent to medical treatment, stand trial, or make a will. Only a court can declare someone incompetent, and only a court can restore that legal status.

The practical implication is significant: a clinician can determine that a patient lacks capacity for a particular decision and act accordingly (e.g., involving a surrogate decision-maker), but that clinician cannot declare the patient legally incompetent. Conversely, a person who has not been adjudicated incompetent is presumed competent under the law, even if a clinician has concerns about their decision-making ability.

The most widely accepted framework for assessing decision-making capacity was articulated by Paul Appelbaum and Thomas Grisso in the 1980s and 1990s. Their four-component model — often called the Appelbaum criteria — provides a structured, reproducible approach to what might otherwise be a subjective clinical judgment. All four abilities must be assessed in relation to the specific decision at hand.

• Understanding: The patient can comprehend the relevant information being disclosed. This includes the nature of the condition, the proposed treatment, the alternatives, and the risks and benefits of each option. Understanding is assessed by asking the patient to paraphrase what they have been told in their own words. Mere repetition is not sufficient — the patient must demonstrate actual comprehension of the material.
• Appreciation: The patient can acknowledge that the disclosed information applies to their own situation. A patient might understand the concept of cancer treatment in the abstract but deny that they personally have cancer despite clear evidence — this would represent a failure of appreciation. Appreciation is often compromised by delusional thinking, severe denial, or anosognosia (lack of insight into one's own illness).
• Reasoning: The patient can engage in a rational process of weighing options and considering consequences. This does not require the patient to reach the same conclusion the clinician would — it requires that the patient can logically manipulate the relevant information, compare alternatives, and articulate how they arrived at their decision. A patient who makes a choice based on delusional premises (e.g., refusing chemotherapy because they believe aliens will cure them) demonstrates impaired reasoning.
• Expressing a choice: The patient can communicate a consistent decision. This is the most basic component. A patient who is catatonic, severely obtunded, or so ambivalent that they cannot state a preference fails this criterion. Importantly, a patient who changes their mind frequently may still meet this criterion if each expressed choice is coherent at the time — but rapid, inexplicable vacillation may warrant closer evaluation.

A patient must demonstrate all four abilities to be considered to have decision-making capacity for the decision in question. The threshold for each ability may be raised or lowered depending on the stakes involved — this is known as the sliding scale approach. A decision with high risks and minimal benefit (such as refusing a simple, life-saving procedure) appropriately demands a higher demonstration of capacity than a low-stakes decision.

Two features of capacity that are essential to understand — and that clinicians frequently get wrong — are its task-specificity and its temporal variability.

Capacity is task-specific. A person does not globally "have" or "lack" capacity. Instead, capacity is assessed in relation to a particular decision. A patient with moderate dementia may lack the capacity to manage complex financial affairs but retain full capacity to decide whether they want to undergo a routine blood draw. A patient with schizophrenia may be unable to appreciate the need for antipsychotic medication (due to delusional beliefs about poisoning) while simultaneously demonstrating clear capacity to choose between two housing options. The question is never "Does this patient have capacity?" but rather "Does this patient have capacity for this specific decision?"

Capacity can fluctuate. A patient who lacks capacity today may regain it tomorrow — or within hours. Delirium is the classic example: a patient may be confused and unable to make decisions at 2 AM but lucid and fully capable by the following morning after the underlying cause (infection, metabolic derangement, medication effect) is addressed. Intoxication impairs capacity transiently. Psychotic episodes resolve with treatment. Even patients with progressive conditions like dementia may have periods of greater lucidity. Clinicians should reassess capacity when clinical circumstances change, rather than treating a single assessment as permanent.

The practical consequence is that clinicians should maximize the patient's opportunity to demonstrate capacity before concluding it is absent. This includes assessing at the optimal time of day, ensuring the patient is not sedated or in pain, using clear and simple language, providing information in the patient's preferred language, and repeating information as needed.

While decision-making capacity is most commonly assessed through unstructured clinical interviews, several standardized instruments have been developed to improve reliability and reduce assessor bias.

The MacArthur Competence Assessment Tool for Treatment (MacCAT-T) is the gold standard research instrument. Developed by Grisso and Appelbaum, it is a semi-structured interview that systematically evaluates all four components of capacity — understanding, appreciation, reasoning, and expressing a choice — in relation to a specific treatment decision. The MacCAT-T takes approximately 15 to 20 minutes to administer and generates quantitative subscale scores. While it does not produce a binary "capable/incapable" determination (that remains a clinical judgment), it provides a structured, documented, and reproducible framework for the assessment.

Other instruments include the MacCAT-CR (for consent to research participation), the Aid to Capacity Evaluation (ACE) — a briefer bedside tool used in Canadian clinical practice — and the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC), a 10-item screening tool that takes under 5 minutes.

Regardless of the tool used, a thorough capacity assessment should include the following elements:

• Disclosure of relevant information in clear, jargon-free language appropriate to the patient's education level and cultural background
• Assessment of each of the four Appelbaum criteria, with specific questions probing each domain
• Consideration of whether any reversible factors (pain, medication effects, delirium, sleep deprivation, anxiety) are impairing the patient's performance
• Documentation of the specific decision in question, the information disclosed, the patient's responses, and the clinician's reasoning for the determination
• A clear statement of the clinical conclusion: the patient does or does not have capacity for the identified decision

Who performs the assessment? Any licensed physician can assess decision-making capacity. This is not a privilege reserved for psychiatrists. In practice, the treating physician (often an internist, surgeon, or emergency physician) makes the initial determination. Psychiatry consultation is typically requested when the assessment is complicated — for example, when a patient with a psychiatric diagnosis is refusing treatment, when the stakes are high, or when there is disagreement among the treatment team.

Capacity questions arise most frequently — and most urgently — in the following clinical situations:

Refusing medication during psychosis. A patient experiencing active delusions may refuse antipsychotic medication because they believe the medication is poison or that they are not ill. This is a paradigmatic case where appreciation and reasoning may be compromised. However, the clinician must still perform a formal assessment rather than assuming incapacity based on the diagnosis alone. Some patients with psychotic disorders retain clear capacity even during symptomatic episodes.

Leaving against medical advice (AMA). When a patient wishes to leave the hospital against the recommendation of their treatment team, a capacity assessment is appropriate if there is reason to believe the decision may stem from impaired judgment. Importantly, many patients who leave AMA do so with full capacity — they simply prioritize different values (e.g., returning home to care for dependents, distrust of the medical system, preference for alternative treatments). Capacity assessment in this context should focus on whether the patient understands the risks of leaving, not on whether the clinician agrees with the decision.

Elderly patients with cognitive decline. Patients with mild cognitive impairment or early dementia often retain capacity for many decisions but may struggle with complex medical choices involving multiple options, probabilistic reasoning, or long-term consequences. The sliding scale approach is particularly relevant: a simple decision (accepting a flu vaccine) requires less cognitive sophistication than a complex one (choosing among several cancer treatment protocols with different risk profiles).

Treatment decisions during manic episodes. Mania impairs judgment, insight, and the ability to appreciate consequences. A manic patient may refuse mood stabilizers because they feel better than they have ever felt and see no reason for treatment. The challenge is distinguishing a preference driven by pathologically elevated mood and grandiosity from a genuine, reasoned choice.

Suicidal patients. Depression can produce a cognitive distortion called hopelessness — the unshakeable belief that one's suffering is permanent and that no intervention will help. This can compromise the appreciation and reasoning components of capacity. A patient who refuses life-saving treatment because they believe death is the only escape from unremitting suffering may lack capacity for that decision, even though they can articulate their reasoning with apparent coherence.

Emergency situations. When a patient lacks capacity and there is an imminent threat to life or limb, clinicians may proceed with emergency treatment under the doctrine of implied consent — the legal presumption that a reasonable person would consent to life-saving treatment if they were able. This exception is narrow and should not be used to override patient autonomy when the situation is not truly emergent.

A psychiatric diagnosis does not automatically mean a patient lacks decision-making capacity. This point cannot be overstated. The presence of a mental illness — even a severe one — is neither necessary nor sufficient for a finding of incapacity. Capacity depends on functional abilities at the time of the assessment, not on diagnostic labels.

Psychotic disorders (schizophrenia, schizoaffective disorder, brief psychotic disorder): Capacity is most commonly compromised when active delusions directly affect the patient's appreciation of their illness or the reasoning behind their treatment decisions. A patient with paranoid delusions about their psychiatrist may lack capacity to refuse the medication that psychiatrist is prescribing — but may retain full capacity for unrelated decisions. Studies using the MacCAT-T have found that approximately 25 to 50 percent of hospitalized patients with schizophrenia have impaired capacity for treatment decisions, meaning that a substantial majority retain capacity even during acute illness.

Bipolar disorder (manic episodes): Mania commonly impairs appreciation (the patient does not believe they are ill) and reasoning (grandiosity and impulsivity distort risk assessment). Depressive episodes may impair capacity through hopelessness and negative cognitive biases. Euthymic patients with bipolar disorder generally have intact capacity.

Major depressive disorder: Most patients with depression retain decision-making capacity. However, severe depression with psychotic features, profound hopelessness, or nihilistic delusions (e.g., Cotard's syndrome — the belief that one is dead or does not exist) can compromise capacity. The key question is whether the depression is producing cognitive distortions that materially affect the patient's ability to appreciate their situation or reason about treatment options.

Delirium: Delirium is arguably the most common cause of impaired capacity in general hospital settings. By definition, delirium involves disturbances in attention and awareness, and it frequently impairs all four components of capacity. Because delirium is typically reversible, the appropriate clinical response is to treat the underlying cause and reassess capacity once the delirium resolves. Elective decisions should be deferred whenever possible.

Dementia: Capacity in dementia depends on the severity and type of cognitive impairment. Patients with mild dementia often retain capacity for many decisions. As the disease progresses, capacity becomes increasingly compromised — but the decline is gradual and uneven. A patient with moderate Alzheimer's disease may still be able to express a clear preference about where they want to live, even if they can no longer manage their finances. Repeated assessments over time, with input from caregivers who know the patient's baseline, are essential.

Intellectual disability: Individuals with intellectual disability are frequently and unjustly presumed to lack capacity. Many individuals with mild to moderate intellectual disability can make informed treatment decisions when information is presented in an accessible format — using plain language, visual aids, and concrete examples. The obligation to optimize the patient's ability to participate in decision-making is especially important in this population.

When a patient is determined to lack capacity for a specific decision, the clinical team must identify an appropriate surrogate decision-maker to authorize treatment on the patient's behalf. The surrogate's authority is not unlimited — it is constrained by ethical and legal standards designed to protect the patient's interests and honor their values.

The hierarchy of surrogate decision-making typically follows a legally defined order of priority, which varies by jurisdiction but generally proceeds as follows:

• Advance directive or living will: A document executed by the patient while competent that specifies their treatment preferences or designates a health care proxy. Advance directives take precedence over other surrogates because they represent the patient's own expressed wishes.
• Health care proxy or durable power of attorney for health care: A person specifically designated by the patient to make medical decisions on their behalf if they lose capacity. This person has decision-making authority as defined in the proxy document.
• Court-appointed guardian or conservator: A person appointed by a court to make decisions for an individual who has been adjudicated legally incompetent. Guardianship may be plenary (covering all decisions) or limited (restricted to specific domains such as medical or financial decisions).
• Next of kin: In the absence of an advance directive, health care proxy, or guardian, most jurisdictions provide a default hierarchy of family members (typically spouse, then adult children, then parents, then siblings) who may serve as surrogate decision-makers.

The surrogate is expected to apply one of two decision-making standards. The substituted judgment standard asks: what would the patient have wanted in this situation, based on their known values, beliefs, and prior expressed preferences? This is the preferred standard when the patient's values are known. When insufficient information exists to infer the patient's preferences, the best interest standard applies: what course of action would a reasonable person in the patient's circumstances choose, weighing the benefits and burdens of each option?

Emergency exceptions allow treatment without consent when there is an immediate threat to life, the patient lacks capacity, and no surrogate is available. This is a narrow exception grounded in the ethical principle of beneficence and the legal doctrine of implied consent. It does not authorize ongoing treatment once the emergency has resolved — at that point, a surrogate must be identified or the patient's capacity must be reassessed.

Capacity assessments sit at the intersection of two foundational bioethical principles: respect for autonomy (the patient's right to make their own decisions) and beneficence (the clinician's obligation to act in the patient's best interest). When these principles conflict — as they do whenever a patient with questionable capacity makes a decision that the treatment team believes is harmful — the capacity assessment becomes the mechanism for resolving the tension.

Several critical ethical points must guide clinical practice:

Refusing treatment does not equal lacking capacity. A competent patient has the legal and ethical right to refuse any medical intervention, including life-saving treatment. The right to refuse is not contingent on the clinician agreeing with the decision or finding it reasonable. Jehovah's Witnesses who refuse blood transfusions, cancer patients who decline chemotherapy, and individuals who choose palliative care over aggressive intervention are all exercising their autonomous right — and clinicians must respect these decisions when they are made with intact capacity, even when the clinician finds them deeply troubling.

Having a psychiatric diagnosis does not mean lacking capacity. Using a diagnostic label as a proxy for incapacity is a form of discrimination that violates patient autonomy and perpetuates the stigma of mental illness. Every patient — regardless of diagnosis — is entitled to a fair, individualized, and functionally oriented capacity assessment when questions arise.

Capacity assessments should not be weaponized. A capacity assessment should be triggered by genuine clinical concern about a patient's decision-making ability — not by the treatment team's disagreement with the patient's choice. Ordering a capacity assessment solely because a patient is refusing recommended treatment, without any clinical evidence of impaired cognition or judgment, is ethically inappropriate and undermines the trust that is foundational to the therapeutic relationship.

The burden of proof falls on those who would override autonomy. Every adult is presumed to have capacity unless there is evidence to the contrary. The clinician asserting incapacity bears the burden of demonstrating — through a structured assessment with documented findings — that the patient's functional abilities are impaired in a way that compromises their decision-making for the specific choice at hand.

These principles reflect a broader commitment in bioethics and mental health law to protecting the rights and dignity of individuals with psychiatric conditions, who have historically been subjected to involuntary treatment, institutionalization, and paternalistic decision-making without adequate safeguards.